Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Bladder Cancer Risk Predicted by Low Levels of Blood in the Urine

By LabMedica International staff writers
Posted on 08 Sep 2014
Blood in the urine, whether visible to the naked eye or not, is an early warning sign for the development of bladder cancer.

Investigators at the University of Exeter Medical School (United Kingdom) reviewed data accumulated between January 2000 and December 2009 to compare levels of blood in the urine (hematuria) in 4,915 patients who were over 40 years old and had been diagnosed with bladder cancer to that found for 21,718 controls matched for age, sex, and practice. More...


They reported that the risk of bladder cancer was 1.6% in individuals over the age of 60 who had blood in their urine that was measurable but not visible to the naked eye.

First author Sarah Price, a pre-doctoral student at the University of Exeter Medical School, said, "It is well known that if you see blood in your urine you should contact your GP, who is likely to refer you for tests. But there is no clear guidance for GPs on what to do if they detect blood that is not visible during routine tests. We are hopeful that our findings will now lead to robust guidance that it warrants further investigation. Early diagnosis is crucial to have the best chance of successfully treating bladder cancer. The three-quarters of patients who are diagnosed early have much better outcomes than those whose disease is diagnosed late. Anything we can do to boost early detection is crucial to help save lives."

The study was published in the September 1, 2014, issue of the British Journal of General Practice.

Related Links:

University of Exeter Medical School



New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
Chromogenic Culture System
InTray™ COLOREX™ ECC
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: MammaPrint is a 70‑gene expression test that stratifies risk of distant metastasis into UltraLow, Low, High 1, and High 2 categories (photo courtesy of Agendia)

Genomic Assays Predict Anthracycline Benefit in Early-Stage Breast Cancer

Anthracycline-based chemotherapy remains a cornerstone of treatment for early-stage, hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer, but its risks of cardiotoxicity... Read more

Microbiology

view channel
Image: New EMBL-led research identifies a robust gut microbiome signature linked to colorectal cancer, consistent across populations, sequencing methods & age groups, and tied to lower dietary fiber intake. (Photo courtesy of Daniela Velasco/EMBL)

Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer

Colorectal cancer has been repeatedly linked to alterations in the gut microbiome, yet findings have often varied across small, heterogeneous studies. Reproducibility has been limited by differing sequencing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.